Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.
about
Quantification of liver fibrosis in chronic hepatitis B virus infection.Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil.Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.Occult Hepatitis B Virus Infection among HIV Positive Patients in NigeriaHepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals.Hepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China.Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data.Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Viral hepatitis in HIV infection.Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection.The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.HIV through the looking glass: insights derived from Hepatitis BPostexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.Hepatitis infection in the treatment of opioid dependence and abuse.Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV.Preventing and treating hepatitis B infection.Five-year review of HIV-hepatitis B virus (HBV) co-infected patients in a New York City AIDS centerDisparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries.Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-Infection Among HIV Infected Individuals at Tertiary Care Hospital in Western Nepal.Hepatitis B and E co-primary infections in an HIV-1-infected patient.HIV/HBV coinfection in children and antiviral therapy.Substance abuse, HIV-1 and hepatitisBaseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India.Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women.Impact of Poor Retention in HIV Medical Care on Hepatitis B Vaccination.HBV infection in HIV-infected subjects in the state of Piauí, Northeast Brazil.Treatment outcomes in a cohort of patients with chronic hepatitis B and human immunodeficiency virus co-infection in Mumbai, India.Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar.Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus.Absence of anti-hepatitis B virus (HBV) core in HIV/HBV coinfection with advanced immunosuppression.Hepatitis in AIDS patients.Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3Hepatitis B virus contact disclosure and testing in Lusaka, Zambia: a mixed-methods studySeroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil
P2860
Q26782440-0784BC34-D048-428B-901D-9884DA0D226CQ33234909-8435F86F-712A-406C-BD55-9F64CFCB658CQ33242705-4FD1ECEF-CFD8-42A0-9A47-4255EC2DA2B9Q33607322-83467551-7D2B-494F-906F-EE8CF469B9FBQ33699077-B7CFA599-1A91-4042-ABD1-1FC4312BCD69Q33794433-B65329D0-B48A-4771-AAF2-7DD44ECA0D93Q33799094-E96B8B61-E85C-41B1-9AA4-FE235DECBB00Q33968358-D7E5B3F7-D418-4469-8236-0C9B1394172DQ34086980-FA043A06-ED4C-4183-8327-BD069E33769FQ34384793-4AD7BB86-0ECE-46DD-9AC9-69AD5443D987Q34514263-5C05D83C-94EE-4C08-9289-DFF159153C84Q34966832-FDD7D280-86E1-489F-94C6-3DF05239AF20Q34977407-B7068AB3-4E95-4364-BA10-DE72DC1FDAAFQ35105851-D35B4737-F13B-4A0B-911D-519F7F9E16E3Q35389163-6EE26A33-E3B8-4054-911F-381BC21A8C11Q35507274-48887149-8BAF-4EE1-A140-97819BDD3C4DQ35940524-5BD151FF-0E8A-4903-B233-107C64DBB6B8Q36079091-A1B6726A-9D6D-43B5-97C1-8A7E44111F0AQ36112876-14418A2E-3D38-42B5-8465-E6342D4B0217Q36504266-8EADC955-3AA8-40A4-8F0A-4A16C9F1C1BAQ36667638-709DBDF6-EFB2-48F9-8BCD-CD4BE721B57FQ36775147-BCDC9353-4ADE-4B6D-B3D8-588F0AA2CD7CQ37003023-A2FBA36A-23B0-480D-8B5D-5F56C2B9FD33Q37186594-7F3ECDCD-414F-4A5F-B172-1B61B3EACB25Q37335253-F587AFF6-0E53-4987-93BF-08F6A63D0033Q38793776-B852F6D6-CDA5-44CF-A3F9-941CF21100D4Q40799450-2D021877-6C54-415D-82EE-57961DC3F29EQ41707376-43832106-3D5A-468E-AEC3-A6ABE9C6583FQ42253874-7AA6CB07-F96B-4500-BB2E-2DBC320B59FFQ42270170-9C9D3CA4-D2AD-4170-ADA6-32037924C1FCQ42288181-9B544D4A-8A99-494D-825C-5674EA012476Q42990814-E02ECDFC-A4B2-491D-884B-70FF3A2681CCQ43035108-79EDBEFE-A0C0-4AAA-B640-F6D6036357D9Q45350550-30F709F3-EE22-4470-8857-CC6086F3C6C9Q48191650-9E39CFD4-7CEF-4ADB-A8F9-A6D56D2D6B06Q55316446-2F6C0032-814C-4745-906C-658CF96B2E3FQ57880260-6322C0DF-482F-4201-B498-65231FD0B07AQ58705026-0E2EFAC2-8D3A-4800-8B24-B76205D297DFQ58760125-D5EF0B94-E5EB-46BB-ADAA-8FB8110481BF
P2860
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis B in the human immun ...... atural history, and treatment.
@ast
Hepatitis B in the human immun ...... atural history, and treatment.
@en
type
label
Hepatitis B in the human immun ...... atural history, and treatment.
@ast
Hepatitis B in the human immun ...... atural history, and treatment.
@en
prefLabel
Hepatitis B in the human immun ...... atural history, and treatment.
@ast
Hepatitis B in the human immun ...... atural history, and treatment.
@en
P356
P1476
Hepatitis B in the human immun ...... atural history, and treatment.
@en
P2093
Chloe L Thio
P304
P356
10.1055/S-2003-39951
P577
2003-05-01T00:00:00Z